Konstance Knox, PhD – CEO Coppe Laboratories
Knox received her bachelor’s degree in medical laboratory sciences from Marquette University and was board certified by the American Society for Clinical Pathology. After receiving a Master’s degree in business management, Knox entered the Medical College of Wisconsin’s graduate pathology program as a doctoral student. There she investigated the pathogenetic interactions between HIV and HHV-6 as her doctoral dissertation research project under Donald Carrigan, PhD, with whom she collaborated on various publications during the period. Knox and Carrigan were founders of Wisconsin Viral Research Group (WVRG) and subsequently created Viracor Laboratories in order to extend testing services. As Viracor expanded, Knox and Carrigan focused on WVRG and expanded research outside United States.
Dr. Knox has received numerous awards and recognitions related to her research in AIDS, MS, Chronic Fatigue Syndrome. Dr. Knox has served as a special reviewer for the National Prion Research Program and the National Institute for Neurologic Disorders and Stroke of the National Institutes of Health. She has also served as a peer reviewer for numerous journals and funding agencies and is a member of the American Society for Microbiology, the Infectious Diseases Society of America, American Association for the Advancement of Science (AAAS), and the Pan American Society for Clinical Virology. She has served on the scientific advisory board of the International Association for Chronic Fatigue Syndrome and also serves as a member of the scientific advisory board of the Wisconsin ME/CSF Foundation.
Dr. Knox formed Coppe Laboratories in order to continue research into specialized infectious disease testing and is committed to providing medical testing in areas of unmet need.
Donald Carrigan, PhD
He and his business partner Dr. Konstance Knox, established a biomedical research and certified viral diagnostic laboratory in Milwaukee, Wisconsin. At Coppe Laboratories, Dr. Carrigan chairs the Scientific Committee and lends his expertise to the viral testing research activities.